Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Waldenstrom Macroglobulinemia × Interleukin-2 × 90 days × Clear all

Sponsor

Conditions

Melanoma 8 Leukemia, Myeloid, Acute 5 Squamous Cell Carcinoma of Head and Neck 3 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Leukemia 3 Carcinoma, Non-Small-Cell Lung 3 Skin Neoplasms 2 Recurrence 2 Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Colorectal Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urogenital Neoplasms 1 Stomach Neoplasms 1 Solid Tumor, Adult 1 Select Advanced Solid Tumors 1 Sarcoma 1 Prostatic Neoplasms 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1

Interventions

zanubrutinib 7 Rituximab 7 ibrutinib 4 venetoclax 3 ixazomib 3 pirtobrutinib 2 Specimen Handling 2 Prednisone 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 CT-P10 2 Bortezomib 2 Biopsy 2 talquetamab 1 fludarabine 1 brexucabtagene autoleucel 1 acalabrutinib 1 Vincristine 1 Valganciclovir 1 Valacyclovir 1 Therapeutics 1 Thalidomide 1 Sirolimus 1 Polymerase Chain Reaction 1 Pharmacogenomic Variants 1 Lenalidomide 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Everolimus 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡